GutiƩrrez, Orlando M. https://orcid.org/0000-0001-6593-3571
Funding for this research was provided by:
national institute of diabetes and digestive and kidney diseases (K24DK116180)
Article History
Accepted: 7 September 2021
First Online: 3 November 2021
Declarations
:
: Dr. Gutierrez reports receiving grant support and honoraria from Amgen and Akebia; grant support from GSK; honoraria from AstraZeneca, Ardelyx, and Reata; and serving on the Data Monitoring Committee for QED Therapeutics.
: This article does not contain any studies with human or animal subjects performed by any of the authors.